Radiolabelled somatostatin analogue(s) for peptide receptor scintigraphy and radionuclide therapy-Reference-Cited by-同舟云学术

Radiolabelled somatostatin analogue(s) for peptide receptor scintigraphy and radionuclide therapy

Published:1999 Issue: Volume:10 Page:S23-S30
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Krenning E.P.,de Jong M.,Kooij P.P.M.,Breeman W.A.P.,Bakker W.H.,de Herder W.W.,van Eijck C.H.J.,Kwekkeboom D.J.,Jamar F.,Pauwels S.,Valkema R.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/10/suppl_2/S23/6672213/10-suppl_2-S23.pdf

Reference29 articles.

1. Cloning, functional expression and pharmacological characterization of a fourth (hSSTR4) and a fifth (hSSTR5) human somatostatin subtype;Yamada;Biochem Biophys Res Commun,1993

2. Somatostatin receptors: Orphan that found family and function;Bruno;Mol Cell Neurosci,1993

3. Cloning and characterization of a fourth human somatostatin receptor;Rohrer;Proc Natl Acad Sci USA,1993

4. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS-201-995 in treatment of human endocrine tumors;Kubota;J Clin Invest,1994

5. In vitro and in vivo studies of substance P receptor expression in rats with the new analog [indium-111-DTPA-Argl]substance P;Breeman;J Nucl Med,1996

Cited by 192 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Somatostatin Radioligand Therapy of Breast Cancer: A Target of Opportunity;Radiology;2024-07-01

2. Combination Strategies and Targeted Radionuclide Therapies;Seminars in Nuclear Medicine;2024-07

3. Biological response of digestive system in experimental study of 177Lu-based compound;Experimental and Clinical Gastroenterology;2024-05-18

4. Long-term clinical outcomes of [177Lu]Lu-DOTATATE in patients with metastatic neuroendocrine tumors;Frontiers in Oncology;2024-05-16

5. Safety, dosimetry, and efficacy of an optimized long-acting somatostatin analog for peptide receptor radionuclide therapy in metastatic neuroendocrine tumors: From preclinical testing to first-in-human study;Acta Pharmaceutica Sinica B;2024-05